Vimarsana
Biggest News Aggregation in the World

Page 28 - End Results Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from End Results Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In End Results Program Today - Breaking & Trending Today

Study reveals rising oropharyngeal cancer incidence and mortality trends in all 50 states - Vimarsana News

Study reveals rising oropharyngeal cancer incidence and mortality trends in all 50 states

Oropharyngeal cancer incidence among men is continuing to rise rapidly in nearly all 50 states and among women living in states in the Midwest and Southeast regions, according to a new study by investigators at The University of Texas Health Science Center at Houston School of Public Health in JAMA Otolaryngology-Head & Neck Surgery.

Decreased lung cancer mortality rates linked to earlier diagnosis - Vimarsana News

Decreased lung cancer mortality rates linked to earlier diagnosis

CT scans and other screenings played a large role in helping to reduce the lung cancer death rate over time.

Servier Pharmaceuticals: Phase 3 Data Demonstrate TIBSOVO (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia - Vimarsana News

Servier Pharmaceuticals: Phase 3 Data Demonstrate TIBSOVO (ivosidenib tablets) in Combination with Azacitidine Significantly Improves Event-Free Survival and Overall Survival in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia

TIBSOVO in combination with azacitidine compared to placebo plus azacitidine also demonstrated significant improvements in complete remission rate, complete remission and complete remission

RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication - Vimarsana News

RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication

RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication - read this article along with other careers information, tips and advice on BioSpace

RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori - Vimarsana News

RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori

RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori - read this article along with other careers information, tips and advice on BioSpace